148 related articles for article (PubMed ID: 23836213)
21. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
[TBL] [Abstract][Full Text] [Related]
22. BMP receptors in kidney.
Kopp JB
Kidney Int; 2000 Nov; 58(5):2237-8. PubMed ID: 11044248
[No Abstract] [Full Text] [Related]
23. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation.
Gilchrist RB; Ritter LJ; Myllymaa S; Kaivo-Oja N; Dragovic RA; Hickey TE; Ritvos O; Mottershead DG
J Cell Sci; 2006 Sep; 119(Pt 18):3811-21. PubMed ID: 16926195
[TBL] [Abstract][Full Text] [Related]
24. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
25. The Bone Morphogenetic Proteins and Their Antagonists.
Mulloy B; Rider CC
Vitam Horm; 2015; 99():63-90. PubMed ID: 26279373
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic protein-7 (BMP7) in chronic kidney disease.
Mitu G; Hirschberg R
Front Biosci; 2008 May; 13():4726-39. PubMed ID: 18508541
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis.
Raida M; Clement JH; Leek RD; Ameri K; Bicknell R; Niederwieser D; Harris AL
J Cancer Res Clin Oncol; 2005 Nov; 131(11):741-50. PubMed ID: 16136355
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
Upton PD; Davies RJ; Tajsic T; Morrell NW
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
[TBL] [Abstract][Full Text] [Related]
29. Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.
Kahata K; Hayashi M; Asaka M; Hellman U; Kitagawa H; Yanagisawa J; Kato S; Imamura T; Miyazono K
Genes Cells; 2004 Feb; 9(2):143-51. PubMed ID: 15009097
[TBL] [Abstract][Full Text] [Related]
30. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
31. The role of bone morphogenetic proteins BMP-2 and BMP-4 and their related postreceptor signaling system (Smads) in distraction osteogenesis of the mandible.
Farhadieh RD; Gianoutsos MP; Yu Y; Walsh WR
J Craniofac Surg; 2004 Sep; 15(5):714-8. PubMed ID: 15346005
[TBL] [Abstract][Full Text] [Related]
32. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
33. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
[TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
Luo DD; Phillips A; Fraser D
Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
[TBL] [Abstract][Full Text] [Related]
35. TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease.
Sartori R; Gregorevic P; Sandri M
Trends Endocrinol Metab; 2014 Sep; 25(9):464-71. PubMed ID: 25042839
[TBL] [Abstract][Full Text] [Related]
36. Expression and regulation of the decoy bone morphogenetic protein receptor BAMBI in the developing avian face.
Higashihori N; Song Y; Richman JM
Dev Dyn; 2008 May; 237(5):1500-8. PubMed ID: 18386821
[TBL] [Abstract][Full Text] [Related]
37. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
38. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
[TBL] [Abstract][Full Text] [Related]
39. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
40. [Kidney diseases and bone morphogenetic protein].
Yanagita M
Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2305-10. PubMed ID: 18044172
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
